Literature DB >> 25595495

Response to commentary by Champ and Klement: Is a ketogenic diet the solution for the hyperglycemia problem in glioblastoma therapy?

Arnulf Mayer1, Peter Vaupel, Hans-Garlich Struss, Alf Giese, Marcus Stockinger, Heinz Schmidberger.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25595495     DOI： 10.1007/s00066-014-0793-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  6 in total

1.  Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism.

Authors:  Gloria Bonuccelli; Aristotelis Tsirigos; Diana Whitaker-Menezes; Stephanos Pavlides; Richard G Pestell; Barbara Chiavarina; Philippe G Frank; Neal Flomenberg; Anthony Howell; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-09-21       Impact factor: 4.534

Review 2.  Blood flow and metabolic microenvironment of brain tumors.

Authors:  P Vaupel
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report.

Authors:  Giulio Zuccoli; Norina Marcello; Anna Pisanello; Franco Servadei; Salvatore Vaccaro; Purna Mukherjee; Thomas N Seyfried
Journal:  Nutr Metab (Lond)       Date:  2010-04-22       Impact factor: 4.169

4.  [How useful are diets against cancer?].

Authors:  J Hübner; S Marienfeld; C Abbenhardt; C M Ulrich; C Löser
Journal:  Dtsch Med Wochenschr       Date:  2012-11-14       Impact factor: 0.628

5.  Ketone body utilization drives tumor growth and metastasis.

Authors:  Ubaldo E Martinez-Outschoorn; Zhao Lin; Diana Whitaker-Menezes; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2012-09-19       Impact factor: 4.534

6.  Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production.

Authors:  Claudia R Oliva; Douglas R Moellering; G Yancey Gillespie; Corinne E Griguer
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.